Ulcerative Colitis Flashcards

1
Q

What is the pattern of disease in UC?

A

Relapsing-remitting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

UC most commonly presents between the ages of ___________ and __________, although diagnosis can be made at any age

A

15

25

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the pattern of inflammation in UC?

A

continuous, extending from the rectum upwards to a varying degree

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Inflammation of the rectum is referred to as ______________, and inflammation of the rectum and sigmoid colon as _____________

A

proctitis

proctosigmoiditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Left-sided colitis refers to disease involving the colon distal to the _______________. Extensive colitis affects the colon proximal to the ____________, and includes pan-colitis, where the ____________ colon is involved

A

splenic flexure

splenic flexure

whole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

______________ colitis refers to disease involving the colon distal to the splenic flexure. ___________ affects the colon proximal to the splenic flexure, and includes _____________, where the whole colon is involved

A

Left-sided

Extensive colitis

pan-colitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the common symptoms of active UC or relapse? (3)

A
  1. Bloody diarrhea
  2. Urgent need to defecate
  3. Abdominal pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the complications of UC? (4)

A
  1. increased risk of CRC
  2. Secondary osteoporosis
  3. VTE
  4. Toxic megacolon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Management of ulcerative colitis is dependent on factors such as _______________, ______________, and _______________

A

clinical severity

extent of disease

patient preference

  • Clinical and laboratory investigations are used to determine the extent and severity of disease and to guide treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Severity is classified as mild, moderate or severe by using the _________________ to assess bowel movements, heart rate, erythrocyte sedimentation rate and the presence of pyrexia, melaena or anaemia

A

Truelove and Witts’ Severity Index

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Severity is classified as mild, moderate or severe by using the Truelove and Witts’ Severity Index to assess: … (6)

A
  1. bowel movements
  2. heart rate
  3. erythrocyte sedimentation rate
  4. presence of pyrexia
  5. melaena
  6. anaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The extent of disease should be considered when choosing the route of administration for aminosalicylates and corticosteroids; whether oral treatment, topical treatment or both are to be used. If the inflammation is _____________, a rectal preparation is adequate but if the inflammation is _____________, systemic medication is required

A

distal

extended

  • Either suppositories or enemas can be offered, taking into account the patient’s preferences
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The extent of disease should be considered when choosing the route of administration for aminosalicylates and corticosteroids; whether oral treatment, topical treatment or both are to be used. If the inflammation is distal, a(n) ______________ preparation is adequate but if the inflammation is extended, ____________ medication is required

A

rectal

systemic

  • Either suppositories or enemas can be offered, taking into account the patient’s preferences
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Rectal __________ preparations and __________ can be used when patients have difficulty retaining liquid enemas

A

foam

suppositories

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Diarrhoea associated with ulcerative colitis is sometimes treated with anti-diarrhoeal drugs (such as ________________ or ______________) on the advice of a specialist; however their use is contraindicated in acute ulcerative colitis as they can increase the risk of toxic megacolon

A

loperamide hydrochloride

codeine phosphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Diarrhoea associated with ulcerative colitis is sometimes treated with anti-diarrhoeal drugs (such as loperamide hydrochloride or codeine phosphate) on the advice of a specialist; however their use is contraindicated in acute ulcerative colitis as they can increase the risk of ________________

A

toxic megacolon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Diarrhoea associated with ulcerative colitis is sometimes treated with anti-diarrhoeal drugs (such as loperamide hydrochloride or codeine phosphate) on the advice of a specialist; however their use is contraindicated in __________________ as they can increase the risk of toxic megacolon

A

acute ulcerative colitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Are anti-diarrheal drugs safe to use in UC?

A

Yes, UNLESS acute UC in which case there is a risk of toxic megacolon

19
Q

A topical aminosalicylate is recommended as first-line treatment for patients with a mild-to-moderate initial presentation or inflammatory exacerbation of ____________

A

proctitis

20
Q

A topical _______________ is recommended as first-line treatment for patients with a mild-to-moderate initial presentation or inflammatory exacerbation of proctitis

A

aminosalicylate

21
Q

If remission of acute proctitis is not achieved within 4 weeks of treatment with topical aminosalicylates, adding a(n) _______________ should be considered. If response remains inadequate, consider addition of a topical or an oral ________________ for 4 to 8 weeks

A

oral aminosalicylate

corticosteroid

22
Q

Monotherapy with _________________ can be considered for patients who prefer not to use enemas or suppositories, although this may not be as effective

A

an oral aminosalicylate

  • If remission is not achieved within 4 weeks, adding a topical or an oral corticosteroid for 4 to 8 weeks should be considered
23
Q

A topical or an oral corticosteroid for ____________ weeks should be considered for patients with UC in whom aminosalicylates are unsuitable

A

4 to 8

24
Q

A(n) _________________ is recommended as first-line treatment for patients with a mild-to-moderate initial presentation or inflammatory exacerbation of proctosigmoiditis or left-sided ulcerative colitis

A

topical aminosalicylate

25
Q

A topical aminosalicylate is recommended as first-line treatment for patients with a mild-to-moderate initial presentation or inflammatory exacerbation of proctosigmoiditis or left-sided ulcerative colitis. If remission is not achieved within 4 weeks, consider adding a(n) _______________, or switching to a(n) _______________ and 4 to 8 weeks of _______________. If response remains inadequate, stop topical treatment and offer an oral aminosalicylate and 4 to 8 weeks of an oral corticosteroid

A

high-dose oral aminosalicylate

high-dose oral aminosalicylate

a topical corticosteroid

26
Q

A topical aminosalicylate is recommended as first-line treatment for patients with a mild-to-moderate initial presentation or inflammatory exacerbation of proctosigmoiditis or left-sided ulcerative colitis. If remission is not achieved within 4 weeks, consider adding a high-dose oral aminosalicylate, or switching to a high-dose oral aminosalicylate and 4 to 8 weeks of a topical corticosteroid. If response remains inadequate, stop topical treatment and offer _____________ and 4 to 8 weeks of _____________

A

an oral aminosalicylate

an oral corticosteroid

(1. Topical ASA
2. Topical ASA + oral ASA or oral ASA + topical CS)
3. Oral ASA + oral CS)

27
Q

What is the first line treatment of mild-moderate extensive UC?

A

Topical ASA + high dose oral ASA

If remission not achieved within 4 weeks, stop topical ASA and offer high dose oral ASA + 4-8 wks of oral CS

28
Q

If remission of mild-moderate extensive UC is not achieved within 4 weeks of starting topical ASA and high dose oral ASA, stop topical aminosalicylate treatment and offer _________________ and _______________.

A

a high-dose oral aminosalicylate

4 to 8 weeks of an oral corticosteroid

29
Q

How is acute severe UC treated?

A

Immediate hospital admission;

*Acute severe ulcerative colitis of any extent can be life-threatening and is regarded as a medical emergency

30
Q

____________________ should be given to induce remission in patients with acute severe ulcerative colitis (at first presentation or an exacerbation) while assessing the need for surgery

A

Intravenous corticosteroids (such as hydrocortisone or methylprednisolone)

31
Q

If intravenous corticosteroids are contra-indicated, declined or cannot be tolerated, then ________________ or ______________ should be considered

A

intravenous ciclosporin [unlicensed indication]

surgery

32
Q

A combination of ______________ with _______________, or ______________ is second line therapy for patients with acute severe UC who have little or no improvement within 72 hours of starting intravenous corticosteroids or whose symptoms worsen despite treatment

A

intravenous ciclosporin

intravenous corticosteroids

surgery

33
Q

______________ can be used to treat acute exacerbations of severely active ulcerative colitis if ciclosporin is contra-indicated or clinically inappropriate

A

Infliximab

34
Q

In patients who experience an initial response to steroids followed by deterioration, stool cultures should be taken to exclude the presence of pathogens; ______________ activation should be considered

A

cytomegalovirus

35
Q

To reduce the chances of relapse occurring, maintenance therapy with ______________ is recommended in most patients with UC.

A

an aminosalicylate

  • Corticosteroids are not suitable for maintenance treatment because of their side-effects
36
Q

Are corticosteroids suitable for maintaining relapse in patients with UC?

A

No due to their side-effects

37
Q

Maintaining remission in UC:
After a mild-to-moderate inflammatory exacerbation of proctitis or proctosigmoiditis,
______________ can be started alone or in combination with an oral aminosalicylate, administered daily or as part of an intermittent regimen (such as twice to three times weekly or the first seven days of each month)

A

a rectal aminosalicylate

  • An oral aminosalicylate can be used alone in patients who prefer not to use enemas or suppositories, although this may not be as effective
38
Q

A _______________ is given to maintain remission in patients after a mild-to-moderate inflammatory exacerbation of left-sided or extensive ulcerative colitis

A

low-dose of oral aminosalicylate

39
Q

When used to maintain remission, single daily doses of oral aminosalicylates can be more effective than multiple daily dosing, but may result in _______________

A

more side-effects

40
Q

Oral _________________ can be considered to maintain remission in UC, if there has been two or more inflammatory exacerbations in a 12-month period that required treatment with systemic corticosteroids, or if remission is not maintained by aminosalicylates, or following a single acute severe episode

A

azathioprine or mercaptopurine [unlicensed indications]

*JAK inhibitors are also used in the treatment of UC

41
Q

Is MTX an effective drug in treating acute UC or maintaining remission?

A

No evidence to support its use in either

42
Q

___________ may be necessary as emergency treatment for severe ulcerative colitis that does not respond to drug treatment

A

Surgery

43
Q

Patients can also choose to have _______________ for unresponsive or frequently relapsing UC that is affecting their quality of life

A

elective surgery

44
Q

Aminosalicylates (ASA) include: (4)

A
  1. Mesalazine
  2. Sulfasalazine
  3. Balsalazide
  4. Olsalazine

(All contain 5-aminosalicylic acid)